NCT00003867View on ClinicalTrials.gov

Irinotecan and Capecitabine in Treating Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 1999

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions
Cancer
Interventions
DRUG

capecitabine

DRUG

irinotecan hydrochloride

Trial Locations (1)

10461

Albert Einstein Comprehensive Cancer Center, The Bronx

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Montefiore Medical Center

OTHER

NCT00003867 - Irinotecan and Capecitabine in Treating Patients With Solid Tumors | Biotech Hunter | Biotech Hunter